Moreover, biological behaviour changes in ovarian cancer cells caused by miR-2053 inhibitors were strengthened by overexpressed SOX4, whereas the effects of miR-2053 mimics were reversed by transfection with LV-SOX4. This evidence concerns the gene SOX4 and ovarian cancer.